Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing
... "We are gratified by the confidence expressed in us by our CRO, the Board members and ... could differ materially from such statements expressed or implied herein as a result of a variety of ... operating performance, as well as other factors expressed from time to time in the Company's periodic ...China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
... or results to be materially different from those expressed or implied in the forward-looking statements. In ... OF OPERATIONS (Amounts expressed in US Dollars) Three ... SHEETS (Audited, amounts expressed in US Dollars) AS OF ...Medicago succesfully expresses VLP antigen for A H1N1 strain
... (VLPs), today announced that it has successfully expressed a new VLP antigen ("H1 VLP") from the influenza A ... America and other countries. The antigen was expressed within 14 days of receiving the DNA sequence with ... new H1 VLP is comparable to other VLPs recently expressed by Medicago such as the New Caledonia strain ...VIRxSYS Publishes New Study on RNA Therapy
... new tricks." Albumin is the most abundantly expressed gene in liver. Results showed that each of the ... spliced into the albumin gene sequence was expressed in high concentrations by liver cells in ... that is used ensures that added RNA was only expressed in liver cells, and not in other cells, which ...SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS
... "We are encouraged by the interest expressed by several potential new partners and our ongoing ... actual results may differ materially from those expressed or implied by such forward-looking statements. ... of ongoing discussions and the level of interest expressed by potential new collaborators; the benefits to ...Stem Cell Innovations, Inc., Files New Patent Application
... actual results to differ materially from those expressed or implied by these forward-looking statements, ... may cause actual results to differ from those expressed or implied by these forward-looking statements. ... results may still differ materially from those expressed in the forward-looking statements as a result of ...China-Biotics, Inc. Reports Second Quarter 2009 Financial Results
... BALANCE SHEETS (Amounts expressed in US Dollars) ... OF OPERATIONS (Amounts expressed in U.S. Dollars) Three ... OF CASH FLOW (Amounts expressed in US Dollars) ...Vical Announces News Release and Conference Call Schedule For Third Quarter 2008 Financial Results
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...Vical to Present at Upcoming Investor Conferences
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...Vical to Present at UBS Global Life Sciences Conference
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...Vaxfectin(R)-formulated Measles DNA Vaccine Could Address Unmet Need for Infants
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...China-Biotics, Inc. Reports First Quarter 2009 Financial Results
... OF OPERATIONS (Amounts expressed in US Dollars) ... BALANCE SHEETS (Amounts expressed in US Dollars) ... OF CASH FLOW (Amounts expressed in US Dollars) ...Ondine Biopharma Announces Second Quarter 2008 Financial Results
... As at (Unaudited - expressed in Canadian dollars) ... LOSS (Unaudited - expressed in Canadian dollars) ... (Unaudited - expressed in Canadian dollars) ...Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science
... that a majority of the Israeli scientists polled expressed a willingness to use special methods that could ... that a majority of the Israeli scientists polled expressed a willingness to use special methods that could ... of risk was raised, one fifth of the total sample expressed a medium or high level of willingness to try ...China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results
... OF OPERATIONS (Amounts expressed in US Dollars) Three months ... BALANCE SHEETS (Audited, amounts expressed in US Dollars) AS OF MARCH ... OF CASH FLOW (Audited, amounts expressed in US Dollars) FOR THE YEARS ...Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA)
... Interleukin Genetics, Inc. (Amex: ILI ), today expressed praise for the passage into law of the Genetic ... actual results may differ materially from those expressed or implied by such forward-looking statements. ... actual results to differ materially from those expressed or implied by such forward-looking statements ...Vical to Present at Upcoming Investor Conferences
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...Vical Announces News Release and Conference Call Schedule for First Quarter 2008 Financial Results
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...ARIUS presents new findings for anti-cancer antibody programs at AACR
... studies using this antibody showed that CD9 is expressed in a variety of human tumor samples, resulting in ... kinases. CD9 is highly and differentially expressed in AML versus normal CD34+CD38- stem cells. ... future results, performance or achievements expressed or implied by such statements. Forward-looking ...ARIUS announces first quarter fiscal 2008 financial results
... any future results, performance or achievements expressed or implied by such statements. Forward-looking ... that could cause such actual events or results expressed or implied by such forward-looking statements to differ materially from any future results expressed or implied by such statements include, but are ...Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science
... in a recent survey on creativity, expressed a willingness to use special methods that could ... of risk was raised, one fifth of the total sample expressed a medium or high level of willingness to try ... states of creativity." "Those scientists who expressed a very strong willingness to use 'methods to put ...Vical Licensee AnGes MG Files NDA in Japan for Collategene Angiogenesis Product
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...Vical to Present at Cowen and Company Health Care Conference
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...Vical to Present at BIO and BVGH Global Health Partnering Event
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...Angiotech announces results for the fourth quarter ended December 31, 2007
... from any results, events or developments expressed or implied by our financial outlook. We expect ... 2006. Amounts, unless specified otherwise, are expressed in U.S. dollars. Financial results are reported ... from any future results, events or developments expressed or implied by such forward-looking statements. ...China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
... OF OPERATIONS (Unaudited; Amounts expressed in US Dollars) Three ... BALANCE SHEETS (Audited, amounts expressed in US Dollars) ... OF CASH FLOW (Unaudited, amounts expressed in US Dollars) ...ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
... breast and pancreatic cancer. CD9 is highly expressed and differentially expressed in AML versus normal stem cells (42.7+10.1% ... future results, performance or achievements expressed or implied by such statements. Forward-looking ...ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
... targeting this novel marker. Trop-2 is a protein expressed on the cell-surface and found in many cancer ... future results, performance or achievements expressed or implied by such statements. Forward-looking ... that could cause such actual events or results expressed or implied by such forward-looking statements to ...ARIUS announces fourth quarter and year-end fiscal 2007 financial results
... Cancer Stem Cell Program - CD9 is more highly expressed in leukemia stems cells than normal stem ... future results, performance or achievements expressed or implied by such statements. Forward-looking ... that could cause such actual events or results expressed or implied by such forward-looking statements to ...